Australian cash for new drugs comes with strings
This article was originally published in Scrip
Executive Summary
The Australian government is to provide an extra Aus$1.3bn (US$1.04bn) over five years to fund the listing of new medicines and vaccines on the Pharmaceutical Benefits Scheme (PBS), as part of a drive to improve patient access to innovative life-saving therapies.